Cingulate Inc. Common Stock
Symbol: CING (NASDAQ)
3.94
▲ (2.60%) 0.100
Company Description:
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.
Key Stats
- Today's Open: $3.84
- Today's High: $4.055
- Today's Low: $3.865
- Today's Volume: 152.30K
- Yesterday Close: $3.84
- Yesterday High: $3.97
- Yesterday Low: $3.775
- Yesterday Volume: 110.78K
- Last Min Volume: 1
- Last Min High: $3.94
- Last Min Low: $3.94
- Last Min VWAP: $3.94
Company Profile
- Name: Cingulate Inc. Common Stock
- Website: https://www.cingulate.com
- Listed Date: 2021-12-08
- Location: KANSAS CITY, KS
- Market Status: Active
- CIK Number: 0001862150
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $20.78M
- Round Lot: 100
- Outstanding Shares: 5.41M
- Asset Type: CS
RECENT FILINGS FOR CING
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-05 | 8-K | View |
| 2025-08-28 | 8-K | View |
| 2025-08-19 | 10-Q | View |
| 2025-08-19 | 8-K | View |
| 2025-08-15 | DEF 14A | View |
| 2025-08-15 | NT 10-Q | View |
| 2025-08-15 | 8-K | View |
| 2025-08-08 | 8-K | View |
| 2025-08-06 | 8-K | View |
| 2025-08-05 | PRE 14A | View |
| 2025-07-30 | 424B3 | View |
| 2025-07-29 | EFFECT | View |
| 2025-07-25 | CORRESP | View |
| 2025-07-25 | S-8 | View |
| 2025-07-25 | S-1/A | View |
| 2025-07-25 | 8-K | View |
| 2025-07-24 | UPLOAD | View |
| 2025-07-22 | S-1 | View |
| 2025-07-22 | 8-K | View |
| 2025-07-10 | 4 | View |
Latest News on CING